Skip to main content

Naproxen

NDC 65862-522 · Aurobindo Pharma Limited

Generic nameNaproxen
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN
Strength500 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

65862-522-01 — 100 TABLET in 1 BOTTLE (65862-522-01)

65862-522-05 — 500 TABLET in 1 BOTTLE (65862-522-05)

65862-522-26 — 2500 TABLET in 1 BOTTLE (65862-522-26)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63629-8511 — Naproxen, 63629-8512 — Naproxen, 63629-8513 — Naproxen, 63629-8514 — Naproxen, 63629-8515 — Naproxen, 65162-188 — Naproxen, 65162-189 — Naproxen, 65162-190 — Naproxen, 65862-520 — Naproxen, 65862-521 — Naproxen, 66267-153 — Naproxen, 66267-373 — Naproxen, 66267-807 — Naproxen, 67046-0499 — Naproxen, 67046-0500 — Naproxen, 67046-0501 — Naproxen, 67046-1553 — Naproxen, 67296-2235 — Naproxen, 68071-2396 — Naproxen, 68071-4006 — NAPROXEN, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels